More articles from MTA II: Endocrine/Neuroendocrine Posters

You have access
Cervical region explored by SPECT-CT vs planar imaging in thyroid carcinoma
Mhiri Aida, Imène Meddeb, Ihsen Slim and Faouzi Ben Slimène

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1908;
You have access
The additional value of non-enhanced CT acquired during 18F-FDG PET/CT in prediction of I-131 ablation success
Arthur Cho, Jiyoun Choi, Kwanhyeong Jo, Yong Hyu Jeong, Hyunjeong Kim, Jae-hoon Lee, Won Jun Kang, Jong Doo Lee and Mijin Yun

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1905;
You have access
Does lemon candy really reduce total amount of radioactivity passing through salivary glands and ducts?
Kunihiro Nakada, Yasusi Satou, Mika Tamura, Reiko Tsuruhara, Ichiro Sakuma and Masayuki Sakurai

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1918;
You have access
The role of the hybrid imaging techniques SPECT/CT and PET/CT in the diagnostic algorithm of patients with carcinoid tumors
Irena Kostadinova

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1921;
You have access
Unraveling brown adipose tissue (BAT) thermogenic makeup using 18F-fluorobenzyl triphenyl phosphonium (FBnTP) and FDG PET in humans
Richard Wahl, John Crandall, Daniel Holt, Hayden Ravert, Robert Dannals and Igal Madar

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1868;
You have access
The value of thyroglobulin measurement in fine needle aspirates from cervical lymph nodes of thyroid cancer patients
Haluk Sayman, Sabire Yilmaz, Serap Nisli, Meftune Ozhan, Lebriz Uslu, Resit Akyel, Fatma Eren, Ethem Erginöz, Sait Sager and Bedii Kanmaz

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1874;
You have access
Recombinant human thyrotropin (rhTSH) versus thyroid hormone withdrawal in the radioiodine residual ablation for differentiated thyroid cancer
Chao Ma

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1858;
You have access
Ablation outcome post a high second ablative dose of radioactive iodine (I131) in patients with papillary thyroid cancer
Shereen Wagieh, Khalid Salman, Sherif El Refaie, Maha Abd El- Kareem, Yasser Mohammad and Manal Al-Ezzi

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1859;
You have access
Clinical experience with integrated thyroid PET/MR in patients with papillary thyroid carcinoma
Ihn Ho Cho, Eun-jung Kong and Ju Hye Jeong

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1860;
You have access
Uterine uptake of [In-111]pentetreotide: SPECT-CT investigation
Rachael Edwards and Satoshi Minoshima

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1875;

Main menu

User menu

Search

More articles from MTA II: Endocrine/Neuroendocrine Posters

Pages